Amerinet Inc., a leading national healthcare group purchasing organization, and Masimo (NASDAQ: MASI), the inventor of Masimo Rainbow Pulse CO-Oximetry™, Masimo Rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, jointly announce a new supplier agreement—offering Amerinet members significant contracted savings on Masimo's complete market-leading line of Pulse CO-Oximeters and sensors.

Effective July 1, 2010, through June 30, 2013, Amerinet members can purchase Masimo standalone (Radical-7®, Rad-87®) and portable (Rad-57®, Pronto-7™) Pulse CO-Oximeters on contract, along with reusable and disposable sensors for all categories of patients (from neonatal, infant/pediatric to adult).

With Masimo Pulse CO-Oximeters, clinicians can noninvasively and continuously measure many blood constituents that previously required invasive procedures, including: hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), and acoustic respiration rate (RRa™), in addition to the gold-standard performance of Measure-Through Motion and Low Perfusion Masimo SET® oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate. Featuring revolutionary Masimo Rainbow SET® Pulse CO-Oximetry™ technology, these advanced patient monitors provide continuous measurements of critical physiological parameters with real-time tracking and trending capabilities that help clinicians to identify patient deterioration sooner—facilitating earlier detection and treatment of potentially life-threatening conditions.